{"schema_version":"secwatch.filing_event.v1","accession":"0001551306-23-000093","form_type":"8-K","ticker":"PGNY","cik":"0001551306","company_name":"Progyny, Inc.","filed_at":"2023-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.482587+00:00","generated_at":"2026-06-08T15:04:06.834541+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Progyny Q3 rev $280.9M (+37% YoY), net income $15.9M; raises FY guidance","bullets":["Record quarterly revenue $280.9M, up 37% YoY; net income $15.9M ($0.16 diluted EPS).","Adjusted EBITDA $50.0M (+43% YoY), margin 17.8% vs 17.0% prior year.","Added 1.3M new covered lives in selling season; clients at 392 vs 282 a year ago; ~100% retention.","Raised FY 2023 revenue guidance to $1,087-1,095M and Adj. EBITDA to $186-188.5M.","First federal government plan win with ~300k covered lives; expects lower margin from this population in 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001551306-23-000093","json":"https://secwatch.observer/filing/0001551306-23-000093.json","markdown":"https://secwatch.observer/filing/0001551306-23-000093.md","text":"https://secwatch.observer/filing/0001551306-23-000093.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1551306/000155130623000093/0001551306-23-000093-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1551306/000155130623000093/pgny-20231107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T15:04:06.834541+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f6a8c2ac5e865cdb75b41b34f9456ce9062dfa01","claim":"Progyny, Inc. reported three-month period ended September 30, 2023 results: revenue $280,891, net income $15,898, EPS $0.16. Guidance raised.","evidence_excerpt":"said Mark Livingston, Progyny’s Chief Financial Officer. Third Quarter 2023 Highlights: (unaudited; in thousands, except per share amounts) 3Q 2023 3Q 2022 Revenue $280,891 $205,371 Gross Profit $62,624 $45,995 Gross Margin 22.3% 22.4% Net Income $15,898 $13,211 Net Income per Diluted Share 1 $0.16 $0.13 Adjusted EBITDA 2 $50,019 $34,957 Adjusted","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1551306/000155130623000093/0001551306-23-000093-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three-month period ended September 30, 2023"},{"label":"Revenue","value":"$280,891"},{"label":"Net income","value":"$15,898"},{"label":"EPS","value":"$0.16"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}